Taysha Gene Therapies TSHA
NASDAQ TSHA
$4.63 -0.11 (-2.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Taysha Gene Therapies (TSHA) Return on Assets [ROA] (2020 - 2026)

Updated

Taysha Gene Therapies (TSHA) posted Return on Assets [ROA] of -36.91% for Q2 2026, up 0.02 percentage points from -36.93% a year earlier and up 1.04 percentage points from the prior quarter.

Analysis

Taysha Gene Therapies (TSHA) Return on Assets [ROA] (2020 - 2026) Analysis & Trends

For FY2025, Taysha Gene Therapies' Return on Assets [ROA] came in at -40.24%, up 10.57 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of -7.00 percentage points (FY2020 to FY2025).
  • In prior years, Taysha Gene Therapies' Return on Assets [ROA] was -50.81% in FY2024 (-1.40 pp), -49.41% in FY2023 (+48.32 pp), -97.72% in FY2022 (-23.83 pp) and -73.89% in FY2021 (-40.65 pp).
  • Quarterly Return on Assets [ROA] has run from a low of -139.85% in Q4 2022 to a high of -28.97% in Q3 2025 over five years.
  • On a year-over-year basis, Return on Assets [ROA] has increased in each of the last five quarters, with an average year-over-year change of +9.89 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q4 2023, with a gain of 99.47 percentage points; the weakest was Q2 2022, with a drop of 76.78 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -37.95% (Q1 2026), -30.71% (Q4 2025) and -28.97% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Taysha Gene Therapies 1.58 Bn 1.58 Bn - -36.91%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -36.91%
Mar 31, 2026 -37.95%
Dec 31, 2025 -30.71%
Sep 30, 2025 -28.97%
Jun 30, 2025 -36.93%
Mar 31, 2025 -54.95%
Dec 31, 2024 -49.69%
Sep 30, 2024 -42.78%
Jun 30, 2024 -41.99%
Mar 31, 2024 -48.59%
Dec 31, 2023 -40.38%
Sep 30, 2023 -82.68%
Jun 30, 2023 -136.03%
Mar 31, 2023 -117.48%
Dec 31, 2022 -139.85%
Sep 30, 2022 -127.18%
Jun 30, 2022 -120.71%
Mar 31, 2022 -101.56%
Dec 31, 2021 -76.79%
Sep 30, 2021 -59.08%
API Access

Taysha Gene Therapies Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=TSHA&period=max&api_key=YOUR_API_KEY